Vetoquinol SA

Report Publication Announcement • Apr 14, 2014

VÉTOQUINOL PUBLISHES ITS REGISTRATION DOCUMENT AND ITS ANNUAL FINANCIAL REPORT RELATIVE TO FISCAL YEAR 2013 (FRENCH VERSION)

The registration document of Vétoquinol relative to fiscal year 2013, including the annual financial report relative to fiscal year 2013, was registered with the Autorité des marchés financiers ("the AMF") on April 11, 2014.

It can be read or downloaded on the websites of:

• Vétoquinol (www.vetoquinol.com)
• the AMF (www.amf-france.org)

It is also available to the public free of charge upon simple request:

• by mail: Vétoquinol

Communication financière Magny-Vernois – BP 189 – 70204 Lure Cedex - France

• by e-mail: relations.investisseurs@vetoquinol.com

• by phone: +33 (0)3 84 62 59 88

The registration document integrates among other:

• the report of the President of the Board of directors on the corporate governance and on the internal control established upon provisions of article L. 225-37 of the French Commercial code;
• the management report;
• the sustainable development report;
• the statutory auditors' reports;
• the information relative to the fees paid to the statutory auditors.

About Vétoquinol

Vétoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.

An independent pure player, Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.

Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vétoquinol employs over 1,850 people. Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

For more information: www.vetoquinol.com.

OUR BUSINESS: ANIMALS. OUR ADVANTAGE: PEOPLE.

For more information, contact:

Investor Relations Marie-Josée AUBRY-ROTA Tel.: +33 (0)3 84 62 59 88 relations.investisseurs@vetoquinol.com

VETOQUINOL KEIMA COMMUNICATION Investor Relations & Media Relations Emmanuel DOVERGNE Tel.: +33 (0)1 56 43 44 63 emmanuel.dovergne@keima.fr